Enhanced activity of vancomycin by encapsulation in hybrid magnetic nanoparticles conjugated to a cell-penetrating peptide

Nanoscale. 2020 Feb 14;12(6):3855-3870. doi: 10.1039/c9nr09687f. Epub 2020 Jan 30.

Abstract

We describe a novel antibiotic delivery system based on magnetic nanoparticles (NPs) conjugated to a cell-penetrating peptide (CPP). Silica-coated iron oxide NPs were produced via a co-deposition method, and coated by a polyvinyl alcohol (PVA) polymeric network via physicochemical binding. Vancomycin (VAN) was then entrapped into this PVA network. A hexapeptide sequence Gly-Ala-Phe-Pro-His-Arg, was synthesized in the solid phase and then conjugated onto the surface of the magnetic NPs. The drug ratio incorporation into the carrier system and drug release were monitored through precise analysis. Confocal microscopy showed that the NPs could be internalized into Staphylococcus aureus and Escherichia coli bacterial cells. The antimicrobial effects of VAN were significantly enhanced by this system with a low dosage of VAN. Advantages include rapid targeted-drug delivery process, drug dose reduction, and equal effects on both Gram-positive and Gram-negative bacteria.

MeSH terms

  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacokinetics
  • Anti-Bacterial Agents / pharmacology*
  • Cell-Penetrating Peptides / chemistry*
  • Cell-Penetrating Peptides / pharmacokinetics
  • Drug Carriers / chemistry
  • Drug Compounding / methods*
  • Escherichia coli / drug effects
  • Magnetite Nanoparticles / chemistry*
  • Microbial Sensitivity Tests
  • Staphylococcus aureus / drug effects
  • Vancomycin / chemistry
  • Vancomycin / pharmacokinetics
  • Vancomycin / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Cell-Penetrating Peptides
  • Drug Carriers
  • Magnetite Nanoparticles
  • Vancomycin